ICYMI: $TRI received $3.5m in second-tranche placement funding, strengthening its balance sheet and advancing Stabl-Im toward the clinic. Stabl-Im enables early, safe, non-invasive detection of brain tumours using stable isotope labelling and standard MRI. announcements.asx.com.au/asx…
2
192
$TRI has received $3.5m in second-tranche placement funding, strengthening its balance sheet and advancing Stabl-Im toward the clinic. Stabl-Im enables early, safe, non-invasive detection of brain tumours using stable isotope labelling and standard MRI. announcements.asx.com.au/asx…
134
ICYMI: $TRI reports positive US veteran trial results using its single-lead #ECG #algorithm to detect current major depressive episodes. Sensitivity 97%, specificity 64%. Study highlights potential for objective, early #mentalhealth screening. announcements.asx.com.au/asx…
2
60
TrivarX (#ASX: $TRI) reports positive US veteran trial results using its single-lead #ECG #algorithm to detect current major depressive episodes. Sensitivity 97%, specificity 64%. Study highlights potential for objective, early #mentalhealth screening. announcements.asx.com.au/asx…
3
56
TrivarX $TRI exercised its Option to acquire Stabl-Im™, a novel imaging technology designed for the early, non-invasive detection of brain tumours. Pending shareholder approval, $TRI.ax will advance regulatory engagement & Phase 1 trial planning. trivarx.com/wp-content/uploa… #health
TrivarX $TRI exercised its Option to acquire Stabl-Im™, a novel imaging technology designed for the early, non-invasive detection of brain tumours. Pending shareholder approval, $TRI.ax will advance regulatory engagement & Phase 1 trial planning. trivarx.com/wp-content/uploa… #health
ICYMI: $TRI Q3 FY25 update
🇺🇸 US mental health trial with VA & GLAVREF completed post quarter-end — targeting detection of cMDE
📊 Interim results: up to 94% sensitivity, 73% specificity
🧬 Deal to acquire Stabl-Im™ cancer diagnostic IP from Nucleics
trivarx.com/wp-content/uploa…
🧠 $TRI Q3 FY25 update
🇺🇸 US mental health trial with VA & GLAVREF completed post quarter-end — targeting detection of cMDE
📊 Interim results: up to 94% sensitivity, 73% specificity
🧬 Deal to acquire Stabl-Im™ cancer diagnostic IP from Nucleics
More: trivarx.com/wp-content/uploa…
ICYMI: TrivarX (#ASX: $TRI) has completed recruitment of 60 patients in its US Veteran-focused #mentalhealth trial with GLAVREF and VA Los Angeles, assessing its single-lead ECG algorithm for depression detection. Final results expected this quarter. trivarx.com/wp-content/uploa…
3
27
TrivarX (#ASX: $TRI) has completed recruitment of 60 patients in its US Veteran-focused #mentalhealth trial with GLAVREF and VA Los Angeles, assessing its single-lead ECG algorithm for depression detection. Final results expected this quarter. trivarx.com/wp-content/uploa…
TrivarX to acquire 100% of Stabl-Im™, a breakthrough brain imaging tech from Nucleics (led by Dr Daniel Tillett).Enables early, non-invasive #MRI detection of brain tumours, a major step in #neurooncology. $4.2M raise to advance development. announcements.asx.com.au/asx… $TRI #Biotech
2
25
TrivarX to acquire 100% of Stabl-Im™, a breakthrough brain imaging tech from Nucleics (led by Dr Daniel Tillett).Enables early, non-invasive #MRI detection of brain tumours, a major step in #neurooncology. $4.2M raise to advance development. announcements.asx.com.au/asx… $TRI #Biotech
TrivarX reports positive interim results from its US #veteran-focused #mentalhealth trial w/ VA Greater Los Angeles Healthcare System. The single-lead #ECG algorithm achieved 94% sensitivity & 64% specificity in detecting major depressive episodes. announcements.asx.com.au/asx… $TRI
2
27
TrivarX reports positive interim results from its US #veteran-focused #mentalhealth trial w/ VA Greater Los Angeles Healthcare System. The single-lead #ECG algorithm achieved 94% sensitivity & 64% specificity in detecting major depressive episodes. announcements.asx.com.au/asx… $TRI
1
25
ICYMI: TrivarX (ASX: TRI) is pleased to provide its Preliminary Final Report ended 30 June 2025: announcements.asx.com.au/asx… $TRI $TRI.ax #ASX
2
110
TrivarX (ASX: TRI) is pleased to provide its Preliminary Final Report ended 30 June 2025: announcements.asx.com.au/asx… $TRI $TRI.ax #ASX
2
94
ICYMI: 📰@MSN: TrivarX $TRI successfully enrolled 30 patients in a clinical trial at West Los Angeles VA Medical Center, aimed at evaluating its novel single-lead #ECG #algorithm for screening major depressive episodes in veterans w/ suspected sleep apnea. msn.com/en-us/health/other/t…
2
100
📰@MSN: TrivarX $TRI successfully enrolled 30 patients in a clinical trial at the West Los Angeles VA Medical Center, aimed at evaluating its novel single-lead #ECG #algorithm for screening major depressive episodes in veterans with suspected sleep apnea. msn.com/en-us/health/other/t…
1
197
ICYMI: TrivarX (#ASX: $TRI) achieved full enrolment of 30 patients in its US #veteran-focused #mentalhealth trial using its novel #ECG #algorithm to detect major depressive episodes. Interim results are under review & will be reported in the coming weeks. announcements.asx.com.au/asx…
3
136
TrivarX (#ASX: $TRI) achieved full enrolment of 30 patients in its US #veteran-focused #mentalhealth trial using its novel #ECG #algorithm to detect major depressive episodes. Interim results are under review and will be reported in the coming weeks. READ: announcements.asx.com.au/asx…
3
109




